Trials / Completed
CompletedNCT01146535
Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment
Pilot Study of Interferon Alpha Lozenges Plus Oseltamivir in the Treatment of Influenza A Infection
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Ainos, Inc. (f/k/a Amarillo Biosciences Inc. · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the safety and effect of interferon-alpha lozenges when used in combination with oseltamivir (Tamiflu) to treat influenza.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Interferon-alpha | 150 IU lozenges bid for 5 days |
| DRUG | Oseltamivir | 75 mg capsules bid for 5 days |
| OTHER | maltose | 200 mg maltose lozenges bid for 5 days |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2010-06-17
- Last updated
- 2013-08-21
Locations
4 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01146535. Inclusion in this directory is not an endorsement.